The Trend Of High Returns At IRadimed (NASDAQ:IRMD) Has Us Very Interested
The Trend Of High Returns At IRadimed (NASDAQ:IRMD) Has Us Very Interested
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an increasing amount of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. And in light of that, the trends we're seeing at IRadimed's (NASDAQ:IRMD) look very promising so lets take a look.
要找到一隻多袋股票,我們應該在一家企業中尋找什麼潛在趨勢?理想情況下,一家企業將呈現兩種趨勢;第一,增長退貨關於已使用資本(ROCE),第二,增加金額已動用資本的比例。如果你看到這個,通常意味著它是一家擁有出色商業模式和大量有利可圖的再投資機會的公司。有鑒於此,我們看到的趨勢IRadimed的(納斯達克:irmd)看起來很有前途,所以讓我們來看看。
Return On Capital Employed (ROCE): What Is It?
資本回報率(ROCE):它是什麼?
If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. The formula for this calculation on IRadimed is:
如果你以前沒有使用過ROCE,它衡量的是一家公司從業務資本中獲得的“回報”(稅前利潤)。IRadimed上的此計算公式為:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
已動用資本回報率=息稅前收益(EBIT)?(總資產-流動負債)
0.24 = US$17m ÷ (US$81m - US$7.6m) (Based on the trailing twelve months to June 2023).
0.24美元=1700萬美元(8100萬美元-760萬美元)(根據截至2023年6月的往績12個月計算)。
Therefore, IRadimed has an ROCE of 24%. That's a fantastic return and not only that, it outpaces the average of 9.7% earned by companies in a similar industry.
所以呢,IRadimed的淨資產收益率為24%。這是一個驚人的回報,不僅如此,它還超過了類似行業公司9.7%的平均回報率。
See our latest analysis for IRadimed
查看我們對IRadimed的最新分析
![roce](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20231013/0-ca78c39940985091aa2bcfab1f58183c-0-35145355e0d16423cce1564f308dd7dd.png/big)
In the above chart we have measured IRadimed's prior ROCE against its prior performance, but the future is arguably more important. If you're interested, you can view the analysts predictions in our free report on analyst forecasts for the company.
在上面的圖表中,我們對比了IRadimed之前的ROCE和它之前的表現,但可以說,未來更重要。如果您感興趣,您可以在我們的免費分析師對該公司的預測報告.
What Can We Tell From IRadimed's ROCE Trend?
我們能從IRadimed的ROCE趨勢中看出什麼?
IRadimed is displaying some positive trends. The numbers show that in the last five years, the returns generated on capital employed have grown considerably to 24%. The amount of capital employed has increased too, by 93%. So we're very much inspired by what we're seeing at IRadimed thanks to its ability to profitably reinvest capital.
IRadimed正在顯示出一些積極的趨勢。這些數位顯示,在過去五年中,資本回報率大幅增長至24%。所使用的資本額也增加了93%。因此,我們對IRadimed所看到的非常鼓舞人心,這要歸功於它能夠有利可圖地進行資本再投資。
The Bottom Line
底線
A company that is growing its returns on capital and can consistently reinvest in itself is a highly sought after trait, and that's what IRadimed has. Since the stock has returned a solid 49% to shareholders over the last five years, it's fair to say investors are beginning to recognize these changes. With that being said, we still think the promising fundamentals mean the company deserves some further due diligence.
一家資本回報率不斷增長、能夠持續對自身進行再投資的公司是一個備受追捧的特徵,而這正是IRadimed所擁有的。過去五年,該公司股票的股東回報率高達49%,可以說,投資者開始意識到這些變化。話雖如此,我們仍然認為,前景看好的基本面意味著該公司值得進行進一步的盡職調查。
If you'd like to know more about IRadimed, we've spotted 2 warning signs, and 1 of them makes us a bit uncomfortable.
如果你想了解更多關於iRadimed的資訊,我們已經發現2個警示標誌,其中的一個讓我們有點不舒服。
If you'd like to see other companies earning high returns, check out our free list of companies earning high returns with solid balance sheets here.
如果您想看到其他公司獲得高回報,請查看我們的免費這裡列出了資產負債表穩健、獲得高回報的公司。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫.或者,也可以給編輯組發電子郵件,地址是暗示Wallst.com。
本文由Simply Wall St.撰寫,具有概括性.我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議.它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況.我們的目標是為您帶來由基本面數據驅動的長期重點分析.請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內.Simply Wall St.對上述任何一隻股票都沒有持倉.